Benchmark Initiates MAMA at Buy as Shorts Quietly Exit

Mama's Creations enters the back half of July with a fresh analyst vote of confidence landing just as the stock absorbs a rough week — a tension worth unpacking.

Benchmark initiated coverage on MAMA this morning with a Buy rating and a $25 price target, adding to DA Davidson's unchanged Buy at $25 maintained last week. The Street is unanimously bullish: four Buy ratings, a consensus target of $21.40, and the Benchmark initiation pushing the high-water mark to $25 — implying roughly 48% upside from Tuesday's close of $16.89. The bull case rests on a track record of ~20% organic growth, distribution expansion, and potential M&A optionality. The bear case is more concentrated: chicken-price volatility feeds directly into gross margins, and any rotation in consumer preferences away from fresh deli could quickly erode the thesis. The stock is down 9.3% on the week and off 5% over the past month, so the Benchmark initiation lands at a bruised entry point rather than a momentum high.

Short interest complicates the picture somewhat, though not dramatically. Bears hold roughly 7% of the free float — meaningful enough to matter, but down 15% from a month ago, with the weekly decline running at just over 3%. That steady cover suggests shorts aren't adding conviction at current levels. The borrow market reinforces that read: cost to borrow is a minimal 0.51%, down sharply from a brief spike above 1.5% on July 6. Availability is exceptionally loose at 636% — more than six shares available to borrow for every one currently lent out — a far cry from any squeeze dynamic. The ORTEX short score has drifted from 54.7 on July 8 down to 49.7 this week, signalling that the short-side pressure that characterized the early-July period has faded.

Options positioning has nudged slightly more cautious but remains far from alarming. The put/call ratio ticked up to 0.23 this week from a month of readings clustered between 0.17 and 0.17, landing about one standard deviation above its 20-day average of 0.19. That's a gentle tilt toward defensive positioning rather than a directional signal — the PCR has traded as high as 0.45 in the past year, so current levels leave plenty of room before options traders look genuinely worried.

Institutional ownership rounds out an active recent ownership picture. BlackRock holds 4.6% of shares and added about 76,000 shares through June. Driehaus Capital built a more aggressive position, adding over 392,000 shares in Q1 — the largest reported addition among the top holders. Wasatch trimmed by 74,000 shares in the same window, providing some offset, but the net institutional flow leans toward accumulation rather than distribution. On the insider side, the COO sold a token 472 shares on July 8 for under $9,000 — a routine exercise, not a signal.

The next scheduled earnings release falls on September 8. The two most recent prints each produced double-digit next-day declines — roughly 10% in both cases — though five-day follow-through was muted, fading to around -0.5% to -1% each time. That pattern suggests the market has been quick to punish misses on the day but has not sustained the selling in the week after. With the Benchmark initiation now setting a $25 target and the stock sitting nearly 30% below that level, the gap between Street conviction and current price is the key tension to track ahead of September's print.